News

This week’s collection of the latest dermatologic studies covers hair matrix cells, comorbidity associations of hidradenitis suppurativa, risk factors of infantile hemangioma, and giant cell collagenomas in a patient with Cowden syndrome.

Barbieri spoke with Dermatology Times to discuss the new guidelines and the recommendations and good practice statements included.

Explore Dermatology Times' coverage of the 2024 Masterclasses in Dermatology conference on topics ranging from artificial intelligence lessons from GI to cardiovascular considerations in psoriasis treatment.

IV antibiotics should play a complementary role in the management of HS as new immunomodulator therapies are developed, researchers concluded.

Officials recently reported the first known fatality from the virus. Here's what health professionals say to watch for.

Researchers sought to expand knowledge of the role of cannabis and its molecular mechanisms in anticancer effects.

Miller, Vice President, Immunodermatology Disease Area Leader, Johnson & Johnson, spoke with Dermatology Times about recently published data supporting JNJ-2113's potential in this indication.

From the February cover: Joseph Zabinski, PhD, MEM, and Stefan Weiss, MD, MBA, FAAD, share their expertise into AI’s capabilities in dermatology and specifically, rare diseases such as generalized pustular psoriasis.

Botox? Iontophoresis? Let us know what you most often recommend to your patients with severe palmar hyperhidrosis.

Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.

Lifileucel is a tumor-derived autologous T cell immunotherapy.

Joel Gelfand, MD, explained how body surface area on patients with psoriasis plays a pivotal role in cardiovascular outcomes.

Almirall now possesses the rights to develop and commercialize NN-8828, particularly in immune inflammatory dermatological diseases.

Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.

David Fisher, MD, PhD, shared pearls on fundamental biology of hair follicles, the dynamics of melanocyte stem cells, and the impact of stress on hair pigmentation.

Discover the evolving landscape of lupus treatment, from the importance of monitoring vitamin D levels to advancements in emerging therapies targeting type 1 interferon and plasmacytoid dendritic cells.

A poster presentation explored the transformative impact of integrating clinical pharmacists into an outpatient dermatology clinic, emphasizing collaborative efforts to enhance patient care and improve outcomes in biologic therapy.

Keep up with the latest headlines in dermatology from the past week, including the commercialization of a skin cancer diagnostic AI in South Korea, cannabis extract's potential in combatting melanoma cells, and more.

AI's transformative impact on medicine, explored by Ryan Stidham, MD, reveals potential applications in dermatology, emphasizing caution, ethical considerations, and the need for collaboration across specialties.

Investigators revealed the development of a non-invasive molecular test utilizing gene expression differences in skin diseases such as atopic dermatitis, psoriasis, and mycosis fungoides, with the potential to accurately diagnose and identify super-responders to targeted systemic therapies.

Alice Gottlieb, MD, PhD, put a spotlight on recent studies and the current psoriasis treatment armamentarium for dermatology clinicians to consider.

Susan Taylor, MD, provided insight into epidemiology, patient quality of life, clinical presentation, therapies, and more at Masterclasses in Dermatology.

Peter Lio, MD, shared alternative medicine approaches and resources that dermatologists and patients can utilize for various skin conditions.

The 2-GEP test is made of 2 biomarkers, LINC00518 and PRAME.

ICYMI, this week we had news about the National Rosacea Society's Seal of Acceptance Program, Dermavant's submitted sNDA for tapinarof cream 1% to treat AD, Galderma's accepted BLA for nemolizumab for the treatment of prurigo nodularis and AD, and more.

Japan is the first country in the world to approve dupilumab for the treatment of chronic spontaneous urticaria (CSU).

Dive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.

An investigation into skin changes at the cellular level provides insight into hyaluronic acid’s benefits.

The combination therapy did not yield any effect in patients with non-segmental vitiligo and prompts additional large studies prior to conclusive efficacy.

The IFPA Forum Roadmap for Asia outlines key advocacy demands and practical strategies to improve psoriatic care throughout the continent.